MediciNova, Inc.
MNOV
$1.52
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 52.07% | 7.21% | -10.48% | -8.91% | -31.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.85% | 54.13% | -7.68% | 5.83% | -22.94% |
| Operating Income | -27.85% | -188.53% | 7.68% | -5.83% | 22.94% |
| Income Before Tax | -36.63% | -294.44% | 8.48% | 5.59% | 31.44% |
| Income Tax Expenses | 83.33% | -- | -- | -- | 7.14% |
| Earnings from Continuing Operations | -36.70% | -294.44% | 8.48% | 5.59% | 31.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.70% | -294.44% | 8.48% | 5.59% | 31.40% |
| EBIT | -27.85% | -188.53% | 7.68% | -5.83% | 22.94% |
| EBITDA | -27.93% | -189.51% | 7.71% | -5.80% | 23.00% |
| EPS Basic | -36.67% | -295.92% | 8.53% | 5.55% | 31.37% |
| Normalized Basic EPS | -36.64% | -294.57% | 8.47% | 5.65% | 31.41% |
| EPS Diluted | -36.67% | -295.92% | 8.53% | 0.00% | 34.68% |
| Normalized Diluted EPS | -36.64% | -294.57% | 8.47% | 5.65% | 31.41% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |